早期滤泡性淋巴瘤的克隆演化与复发:一棵多分支的树
该文评论《The Journal of Pathology》新研究:对仅接受放疗的早期滤泡性淋巴瘤(FL)原发与复发样本(含转化)用体细胞突变和重排免疫球蛋白序列分析克隆关系,多数配对样本呈共同前体来源的分支演化,部分病例克隆无关,提示复发或转化为前体池新发克隆或第二肿瘤。
要点
- 早期FL放疗后复发多数源自共同前体的分支演化,而非线性获得突变。
- 复发/转化可来自克隆相关的前体细胞池,也可为克隆无关的第二肿瘤。
- 分析克隆关系宜联合体细胞突变与重排免疫球蛋白序列标记。
核心结论
- 多数早期FL复发或转化并非线性进展,而是来自共同前体的分支演化或克隆无关的第二肿瘤。
研究设计与样本
- 对仅接受放疗的早期FL原发与复发(含或不含转化)配对样本,用体细胞突变和重排免疫球蛋白序列分析克隆关系与演化。
主要发现
- 多数配对淋巴瘤样本显示来自共同(可能为前恶性)祖细胞的分支演化,兼具共享与私有突变。
- 部分病例鉴定为克隆无关。
- 复发或转化可为克隆相关、长寿命、低增殖前体细胞池的新生克隆,或无关第二肿瘤。
临床怎么用
- 解读早期FL放疗后复发/转化时,应考虑分支演化或第二肿瘤,而非默认线性进展与治疗耐药。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Follicular lymphoma (FL) is an indolent B-cell neoplasm characterised by multistep evolution from premalignant precursor cells carrying the hallmark t(14;18) translocation in the majority of cases. In a new article in The Journal of Pathology, samples of relapsed early-stage FL - primary manifestation and relapse with or without transformation - initially treated with radiotherapy only, were studied for clonal relationships and evolution. Using somatic mutations and the rearranged immunoglobulin sequences as markers, the majority of paired lymphoma samples showed so-called branched evolution from a common, possibly premalignant progenitor cell, with both shared and private mutations. In addition, clonally unrelated cases were identified. This and previous studies with similar findings clearly document that relapse or transformation of FL in many instances not necessarily represents a linear progression of disease due to acquisition of additional mutations and therapy resistance, but rather new outgrowths derived from a pool of clonally related, long-lived, and low proliferating precursor cells, or even unrelated second neoplasms. © 2024 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.
引用
- Fend F, Quintanilla-Martinez L. Clonal evolution and relapse in early-stage follicular lymphoma - a tree with many branches†. J Pathol. 2024. PMID: 38775014. doi:10.1002/path.6294
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。